A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Recruiting · NCT06271512 · Registry updated 2025-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Recruiting | Not stated | 2025-02-11 | NCT06271512 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Center for International Blood and Marrow Transplant Research | 16 |
| Genetix Biotherapeutics Inc. | 7 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Cohen Children's Medical Center | New Hyde Park | United States | 16 |
| Stanford University | Palo Alto | United States | 1 |
| Texas Children's Hospital | Houston | United States | 187 |
| UCSF Benioff Children's Hospitals | Oakland | United States | 2 |
| University of Minnesota | Minneapolis | United States | 325 |